Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Liver Diseases

  Free Subscription


26.02.2018

2 Am J Pathol
1 Anticancer Res
2 Biochem Biophys Res Commun
2 BMC Cancer
1 Cancer
2 Dig Dis Sci
1 Endoscopy
2 Eur Radiol
2 Gastroenterology
2 Hepatology
2 Indian J Gastroenterol
2 J Gastroenterol Hepatol
16 J Hepatol
1 N Engl J Med
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Pathol

  1. CHIYONOBU N, Shimada S, Akiyama Y, Mogushi K, et al
    Fatty acid binding protein 4 (FABP4) overexpression in intratumoral hepatic stellate cells within hepatocellular carcinoma with metabolic risk factors.
    Am J Pathol. 2018 Feb 15. pii: S0002-9440(17)30959.
    PubMed     Text format     Abstract available

  2. PANT A, Kopec AK, Baker KS, Cline-Fedewa H, et al
    Plasminogen Activator Inhibitor-1 Reduces tPA-Dependent Fibrinolysis and Intrahepatic Hemorrhage in Experimental Acetaminophen Overdose.
    Am J Pathol. 2018 Feb 15. pii: S0002-9440(17)30859.
    PubMed     Text format     Abstract available


    Anticancer Res

  3. CEAUSU AR, Ciolofan A, Cimpean AM, Magheti A, et al
    The Mesenchymal-Epithelial and Epithelial-Mesenchymal Cellular Plasticity of Liver Metastases with Digestive Origin.
    Anticancer Res. 2018;38:811-816.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  4. ZHU Q, Lu G, Luo Z, Gui F, et al
    CircRNA circ_0067934 promotes tumor growth and metastasis in hepatocellular carcinoma through regulation of miR-1324/FZD5/Wnt/beta-catenin axis.
    Biochem Biophys Res Commun. 2018 Feb 16. pii: S0006-291X(18)30350.
    PubMed     Text format     Abstract available

  5. CAO J, Mi Y, Shi C, Bian Y, et al
    First-line anti-tuberculosis drugs induce hepatotoxicity: A novel mechanism based on a urinary metabolomics platform.
    Biochem Biophys Res Commun. 2018 Feb 15. pii: S0006-291X(18)30259.
    PubMed     Text format     Abstract available


    BMC Cancer

  6. PINATO DJ, Pai M, Reccia I, Patel M, et al
    Preliminary qualification of a novel, hypoxic-based radiologic signature for trans-arterial chemoembolization in hepatocellular carcinoma.
    BMC Cancer. 2018;18:211.
    PubMed     Text format     Abstract available

  7. HEUBLEIN S, Albertsmeier M, Pfeifer D, Loehrs L, et al
    Association of differential miRNA expression with hepatic vs. peritoneal metastatic spread in colorectal cancer.
    BMC Cancer. 2018;18:201.
    PubMed     Text format     Abstract available


    Cancer

  8. KIM HS, Shaib WL, Zhang C, Nagaraju GP, et al
    Phase 1b study of pasireotide, everolimus, and selective internal radioembolization therapy for unresectable neuroendocrine tumors with hepatic metastases.
    Cancer. 2018 Feb 16. doi: 10.1002/cncr.31192.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  9. WEI M, Ford J, Li Q, Jeong D, et al
    Hospital Cirrhosis Volume and Readmission in Patients with Cirrhosis in California.
    Dig Dis Sci. 2018 Feb 19. pii: 10.1007/s10620-018-4964.
    PubMed     Text format     Abstract available

  10. MAIER MM, Zhou XH, Chapko M, Leipertz SL, et al
    Hepatitis C Cure Is Associated with Decreased Healthcare Costs in Cirrhotics in Retrospective Veterans Affairs Cohort.
    Dig Dis Sci. 2018 Feb 16. pii: 10.1007/s10620-018-4956.
    PubMed     Text format     Abstract available


    Endoscopy

  11. HASHIM A, Chen YI, Valenti D, Metrakos P, et al
    Endosonography-guided hepatogastrostomy post-percutaneous biliary drainage in collaboration with interventional radiology.
    Endoscopy. 2018 Feb 16. doi: 10.1055/s-0044-101252.
    PubMed     Text format    


    Eur Radiol

  12. DE CECCO CN, Caruso D, Schoepf UJ, De Santis D, et al
    A noise-optimized virtual monoenergetic reconstruction algorithm improves the diagnostic accuracy of late hepatic arterial phase dual-energy CT for the detection of hypervascular liver lesions.
    Eur Radiol. 2018 Feb 19. pii: 10.1007/s00330-018-5313.
    PubMed     Text format     Abstract available

  13. LUO X, Wang X, Yu J, Zhu Y, et al
    Transjugular intrahepatic portosystemic shunt creation: three-dimensional roadmap versus CO2 wedged hepatic venography.
    Eur Radiol. 2018 Feb 19. pii: 10.1007/s00330-018-5316.
    PubMed     Text format     Abstract available


    Gastroenterology

  14. TEDESCO D, Thapa M, Chin CY, Ge Y, et al
    Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic gammadelta T-cell Receptor-positive Cells and Pathogenesis of Cholestatic Liver Disease.
    Gastroenterology. 2018 Feb 15. pii: S0016-5085(18)30214.
    PubMed     Text format     Abstract available

  15. DOU C, Liu Z, Tu K, Zhang H, et al
    P300 Acetyltransferase Mediates Stiffness-Induced Activation of Hepatic Stellate Cells Into Tumor-promoting Myofibroblasts.
    Gastroenterology. 2018 Feb 15. pii: S0016-5085(18)30209.
    PubMed     Text format     Abstract available


    Hepatology

  16. LEBEAUPIN C, Vallee D, Rousseau D, Patouraux S, et al
    Bax Inhibitor-1 protects from Non-Alcoholic Steatohepatitis by limiting IRE1alpha signaling.
    Hepatology. 2018 Feb 19. doi: 10.1002/hep.29847.
    PubMed     Text format     Abstract available

  17. CHEN H, Shen F, Sherban A, Nocon A, et al
    DEPTOR Suppresses Lipogenesis and Ameliorates Hepatic Steatosis and Acute-on-Chronic Liver Injury in Alcoholic Liver Disease.
    Hepatology. 2018 Feb 19. doi: 10.1002/hep.29849.
    PubMed     Text format     Abstract available


    Indian J Gastroenterol

  18. GUPTA P, Choksi M, Goel A, Zachariah U, et al
    Maintenance zinc therapy after initial penicillamine chelation to treat symptomatic hepatic Wilson's disease in resource constrained setting.
    Indian J Gastroenterol. 2018 Feb 19. pii: 10.1007/s12664-018-0829.
    PubMed     Text format     Abstract available

  19. VEGIRAJU VK, Shetty S, Leelakrishnan V, Janarthanan K, et al
    Role of noninvasive markers to predict the presence of esophageal varices in cirrhosis: Pilot study.
    Indian J Gastroenterol. 2018 Feb 17. pii: 10.1007/s12664-018-0834.
    PubMed     Text format    


    J Gastroenterol Hepatol

  20. WIGG AJ, Chin JK, Muller KR, Ramachandran J, et al
    A Chronic Disease Management Model for Cirrhosis is Cost-Effective: Analysis of a Randomized Controlled Trial.
    J Gastroenterol Hepatol. 2018 Feb 20. doi: 10.1111/jgh.14127.
    PubMed     Text format     Abstract available

  21. KIM TH, Ku DH, Um SH, Lee HA, et al
    How can we improve the performance of MELDNa score in patients with HBV-related decompensated liver cirrhosis commencing antiviral treatment?
    J Gastroenterol Hepatol. 2018 Feb 20. doi: 10.1111/jgh.14128.
    PubMed     Text format     Abstract available


    J Hepatol

  22. YOON YI, Song GW, Lee SG, Hwang S, et al
    Outcome of ABO-incompatible adult living-donor liver transplantation for patients with hepatocellular carcinoma.
    J Hepatol. 2018 Feb 13. pii: S0168-8278(18)30113.
    PubMed     Text format     Abstract available

  23. ZHANG P, Ge Z, Wang H, Feng W, et al
    Prolactin improves hepatic steatosis via CD36 pathway.
    J Hepatol. 2018 Feb 13. pii: S0168-8278(18)30115.
    PubMed     Text format     Abstract available

  24. DUAN F, Wu H, Jia D, Wu W, et al
    O-GlcNAcylation of RACK1 promotes hepatocellular carcinogenesis.
    J Hepatol. 2018 Feb 14. pii: S0168-8278(18)30119.
    PubMed     Text format     Abstract available

  25. NISHIZAWA N, Ito Y, Eshima K, Ohkubo H, et al
    Inhibition of microsomal prostaglandin E synthase-1 facilitates liver repair after hepatic injury in mice.
    J Hepatol. 2018 Feb 16. pii: S0168-8278(18)30126.
    PubMed     Text format     Abstract available

  26. COENRAAD MJ, Porcher R, Bendtsen F
    Hepatic and cardiac hemodynamics and systemic inflammation in cirrhosis: it takes three to tango.
    J Hepatol. 2018 Feb 17. pii: S0168-8278(18)30124.
    PubMed     Text format     Abstract available

  27. LI J, Lei Z, Wang K, Shen F, et al
    Reply to "Antiviral therapy improves survival in patients with HBV infection and intrahepatic cholangiocarcinoma undergoing liver resection: novel concerns".
    J Hepatol. 2018 Feb 17. pii: S0168-8278(18)30127.
    PubMed     Text format    

  28. HOCQUELET A, Aube C, Rode A, Cartier V, et al
    Comparison of no-touch multi-bipolar vs. monopolar radiofrequency ablation for small HCC.
    J Hepatol. 2017;66:67-74.
    PubMed     Text format     Abstract available

  29. POISSON J, Lemoinne S, Boulanger C, Durand F, et al
    Liver sinusoidal endothelial cells: Physiology and role in liver diseases.
    J Hepatol. 2017;66:212-227.
    PubMed     Text format     Abstract available

  30. GUIXE-MUNTET S, de Mesquita FC, Vila S, Hernandez-Gea V, et al
    Cross-talk between autophagy and KLF2 determines endothelial cell phenotype and microvascular function in acute liver injury.
    J Hepatol. 2017;66:86-94.
    PubMed     Text format     Abstract available

  31. TREBICKA J
    Emergency TIPS in a Child-Pugh B patient: When does the window of opportunity open and close?
    J Hepatol. 2017;66:442-450.
    PubMed     Text format     Abstract available

  32. HASHIDA R, Kawaguchi T, Bekki M, Omoto M, et al
    Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review.
    J Hepatol. 2017;66:142-152.
    PubMed     Text format     Abstract available

  33. STICKEL F, Moreno C, Hampe J, Morgan MY, et al
    The genetics of alcohol dependence and alcohol-related liver disease.
    J Hepatol. 2017;66:195-211.
    PubMed     Text format     Abstract available

  34. MA J, Hwang SJ, Pedley A, Massaro JM, et al
    Bi-directional analysis between fatty liver and cardiovascular disease risk factors.
    J Hepatol. 2017;66:390-397.
    PubMed     Text format     Abstract available

  35. TAPPER EB, Saini SD, Sengupta N
    Extensive testing or focused testing of patients with elevated liver enzymes.
    J Hepatol. 2017;66:313-319.
    PubMed     Text format     Abstract available

  36. GARIANI K, Ryu D, Menzies KJ, Yi HS, et al
    Inhibiting poly ADP-ribosylation increases fatty acid oxidation and protects against fatty liver disease.
    J Hepatol. 2017;66:132-141.
    PubMed     Text format     Abstract available

  37. FUCHS CD, Paumgartner G, Wahlstrom A, Schwabl P, et al
    Metabolic Preconditioning Protects BSEP/ABCB11-/- Mice against Cholestatic Liver Injury.
    J Hepatol. 2016 Sep 1. pii: S0168-8278(16)30482.
    PubMed     Text format     Abstract available


    N Engl J Med


  38. Nonalcoholic Steatohepatitis.
    N Engl J Med. 2018;378:779-781.
    PubMed     Text format    


    PLoS One

  39. KAWAGUCHI T, Shima T, Mizuno M, Mitsumoto Y, et al
    Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers.
    PLoS One. 2018;13:e0185490.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: